Finland· FI-REL-REL4501

Isathal Vet.

A fusidiinihappo product containing fusidic acid hemihydrate, registered in Finland by Dechra Veterinary Products A/S. The same ATC class is registered in 2 of our 19 countries.

ATC QS01AA13

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedIsathal Vet.ATCQS01AA13REGISTER NO.FI-REL-REL4501PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Fusidic acid hemihydrate is registered in 2 of 19 countries.

Countries holding a registration under ATC QS01AA13 (fusidiinihappo), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Fusidic acid hemihydrate · ATC QS01AA13

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Fusidic acid hemihydrate
Manufacturer
Dechra Veterinary Products A/S
Country
Finland (FI)
ATC code
QS01AA13
ATC class
Fusidiinihappo
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fusidic acid hemihydrate in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fusidic acid hemihydrate products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Bulgaria · Фуситалмик
  • Germany · Fucithalmic
  • Greece · Fusidic Αcid Promopharma
  • Ireland · Fucithalmic
  • Italy · Fucithalmic
  • Malta · Fucithalmic
  • Norway · Fucithalmic
  • Poland · Fusacid
  • Romania · Fucithalmic
  • Sweden · Fucithalmic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/35b0e41c-b0be-4706-9971-622cb77c7767
GET /v1/drugs/35b0e41c-b0be-4706-9971-622cb77c7767?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "silmätipat, suspensio",
  "route": "Silmän pinnalle",
  "ddd_unit": null,
  "strength": "1 %",
  "atc_label": "Fusidiinihappo",
  "ma_number": "12375",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL4501",
  "authorised_at": "1997-09-15"
}

See everything about fusidic acid hemihydrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.